Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex ), in a depot formulation, to premenopausal women
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 49 (1) , 163-165
- https://doi.org/10.1016/s0015-0282(16)59670-8
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist d-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancerJournal of Endocrinology, 1986
- TREATMENT OF PATIENTS WITH ADVANCED CANCER OF THE PROSTATE USING A SLOW-RELEASE (DEPOT) FORMULATION OF THE LHRH AGONIST ICI 118630 (ZOLADEX®)Journal of Endocrinology, 1984
- CLINICAL APPLICATIONS OF LHRH AND ITS ANALOGUESClinical Endocrinology, 1983